Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Reem Alasbali
Observed name:
Reem Abdullah Alasbali
Institutions:
King Faisal Specialist Hospital & Research Centre,
Princess Margaret Cancer Centre
Observed institutions:
King Faisal Specialist Hospital & Research Centre,
Princess Margaret Cancer Centre,
Asir Central Hospital
ORCID:
0000-0002-7464-3637
Observed ORCID:
0000-0002-7464-3637
OpenAlex ID:
A5068448064
Autoimmune pulmonary alveolar proteinosis successfully treated with lung lavage in an adolescent patient: a case report
2021
·
Abdalla Mohmed Alasiri
, Reem Abdullah Alasbali
, et al.
·
Journal of Medical Case Reports
·
8
PDF
Excellent Outcomes of HLA Matched Related Donor Transplant for Adults with Severe Sickle Cell Disease Using a Non-Myeloablative Conditioning with Thiotepa and Post-Transplant Cyclophosphamide: Multi-Center International Experience
2023
·
Reem Alasbali
, Mohsen Alzahrani
, et al.
·
Blood
·
5
Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series
2025
·
Ali D. Alahmari
, Saad Alghamdi
, et al.
·
Communications Medicine
·
2
PDF
Steroid Pre-Busulfan Based Reduced-Intensity Conditioning in Matched Related Hematopoietic Stem Cell Transplantation: Outcomes in Young and Adult Sickle Cell Disease Patients
2024
·
Abdulrahman Nasiri
, Sarah Samarkandi
, et al.
·
Blood
·
2
PDF
Excellent Outcomes Using a Non-Myeloablative Conditioning with Thiotepa and Post -Transplant Cyclophosphamide in Adults Undergoing a Matched Related Donor Bone Marrow Transplant for Severe Sickle Cell Disease
2024
·
Reem Alasbali
, Mohsen Alzahrani
, et al.
·
Transplantation and Cellular Therapy
·
2
Induction of Immune Tolerance after Haploidentical Stem Cell Transplantation Following Solid Organ Transplantation in Patients with Sickle Cell Disease
2026
·
Ali Alahmari
, Saad Alghamdi
, et al.
·
Transplantation and Cellular Therapy
·
1
The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL, Real World Data, Single Institution Experience
2023
·
Reem Alasbali
, Abdulrahman Nasiri
, et al.
·
Blood
·
1
Superior Outcome of Bone Marrow Transplantation Using Fludarabine and Cyclophosphamide with ATG over Fludarabine and Cyclophosphamide without ATG Conditioning Regimen in Severe Aplastic Anemia
2023
·
Reem Alasbali
, Riad O. El Fakih
, et al.
·
Blood
·
1
Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease
2026
·
Reem Alasbali
, Mohsen Alzahrani
, et al.
·
Bone Marrow Transplantation
Validation of the Refined ELN 2022 AML Risk Stratification Incorporating an Adverse-Plus Category and Impact on Allogeneic Transplant Outcome
2026
·
Reem Alasbali
, Carlos Jiménez-Vicente
, et al.
·
Transplantation and Cellular Therapy
Post-transplant monitoring of multiparameter flow-cytometry (MFC)-based measurable residual disease (MRD) assessment combined with T-cell chimerism following allogeneic stem cell transplantation (HCT) in Acute Myeloid Leukemia (AML) and myelodysplastic syndrome (MDS)
2025
·
Reem Alasbali
, Majed Altareb
, et al.
·
Blood
PDF
Immune tolerance induction after haploidentical stem cell transplant following organ transplantation in sickle cell disease
2025
·
Ali Alahmari
, Saad Alghamdi
, et al.
·
Blood
PDF
Author Correction: Haplo-stem cell transplant post liver transplantation to cure sickle cell disease with related liver dysfunction: a case series
2025
·
Ali D. Alahmari
, Saad Alghamdi
, et al.
·
Communications Medicine
PDF
Prognostic Impact of CD19 Status Pre-Lymphodepletion in Anti-CD19 CAR-T Therapy for B-Acute Lymphoblastic Leukemia
2024
·
Nourah Alzaidy
, Mostafa Faisal Mohammed Saleh
, et al.
·
Blood
The Outcome of Tisagenlecleucel (Tisa-Cel) Vs Axicabtagene Ciloleucel (Axi-Cel) CD-19 CAR-T Cell Therapy in Relapsed/Refractory NHL: Real World Data from a Single Institution Experience
2024
·
Reem Alasbali
, Abdulrahman Nasiri
, et al.
·
Transplantation and Cellular Therapy
Favorable Outcomes in Severe Aplastic Anemia Patients Undergoing Allo-HSCT with Fludarabine, Cyclophosphamide, and ATG Conditioning
2024
·
Reem Alasbali
, Riad El Fakih
, et al.
·
Transplantation and Cellular Therapy
Molecular Characterisation and Outcomes of 363 Adolescent and Young Adults with AML in Saudi Arabia Risk Stratified By PCR and NGS-Based Testing
2023
·
Manar Alfaham
, Ahmad S. Alotaibi
, et al.
·
Blood
PDF
POSTER: ABCL-647 The Outcome of Tisagenlecleucel (Tisa-Cel) CD-19 CAR-T Cell Therapy in NHL Relapsed/Refractory Beyond Second Line of Therapy, Single-Center Data
2023
·
Reem Alasbali
, Abdulrahman Nasiri
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
ABCL-647 The Outcome of Tisagenlecleucel (Tisa-Cel) CD-19 CAR-T Cell Therapy in NHL Relapsed/Refractory Beyond Second Line of Therapy, Single-Center Data
2023
·
Reem Alasbali
, Abdulrahman Nasiri
, et al.
·
Clinical Lymphoma Myeloma & Leukemia
P1420: Comparative Study of Cyclosporine Versus Tacrolimus in Addition to Methotrexate as Graft Versus Host Disease Prophylaxis in Matched Sibling Allogeneic Stem Cell Transplantation of Sickle Cell Disease
2023
·
Samar Alfaqawi
, Mostafa Mohammed Saleh
, et al.
·
HemaSphere
Show more works
View as search
Works count:
20
Citation count:
22
H-index:
2
I10-index:
Year
Topic
Type